Ultimovacs AS Registered Shs Aktie 48073435 / NO0010851603
2.55
NOK
-0.10
NOK
-3.77%
20.12.2024
OSL
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Ultimovacs AS Registered Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Ultimovacs AS Registered Shs | 0.00 | 0.00 | NOK |
| 2022 | Ultimovacs AS Registered Shs | 0.00 | 0.00 | NOK |
| 2021 | Ultimovacs AS Registered Shs | 0.00 | 0.00 | NOK |
| 2020 | Ultimovacs AS Registered Shs | 0.00 | 0.00 | NOK |
| 2019 | Ultimovacs AS Registered Shs | 0.00 | 0.00 | NOK |
| 2018 | Ultimovacs AS Registered Shs | - | - | NOK |
| 2017 | Ultimovacs AS Registered Shs | - | - | NOK |
| 2016 | Ultimovacs AS Registered Shs | - | - | NOK |
Zu diesem Datensatz liegen uns leider keine Daten vor.
Ultimovacs AS Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Ultimovacs AS Registered Shs | Quartalszahlen | 13.02.2025 |
| Ultimovacs AS Registered Shs | Quartalszahlen | 07.05.2025 |
| Ultimovacs AS Registered Shs | Quartalszahlen | 15.08.2025 |
| Ultimovacs AS Registered Shs | Quartalszahlen | 06.11.2025 |
| Ultimovacs AS Registered Shs | Quartalszahlen | 12.02.2026 |
Ultimovacs AS Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 06.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 21.08.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 07.05.2024 |
| Hauptversammlung | Annual General Meeting | 18.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 14.02.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 08.11.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 22.08.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 10.05.2023 |
| Hauptversammlung | Annual General Meeting | 20.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 16.02.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 10.11.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 19.08.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 12.05.2022 |
| Hauptversammlung | Annual General Meeting | 21.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 17.02.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 43.48 |
| Bjørn Rune Gjelsten | 18.89 |
| Wilhelmsen Family | 5.18 |
| Hagen Stein Erik Family | 4.96 |
| Radiumhospitalets Forskningsstiftelse | 4.42 |
| Langøya Invest AS | 4.06 |
| Inven2 AS | 3.99 |
| Else Helene Sundt | 2.81 |
| Christian Gruner Sundt | 2.56 |
| Sundt AS | 2.34 |
| Månebakken AS | 1.70 |
| Gustav Gaudernack | 1.55 |
| Kjetil Myrlid Aasen | 1.16 |
| SEB Prime Solutions - Sissener Canopus | 1.07 |
| Handelsbanken Norden Index Criteria | 1.01 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 11 | 16 | 19 | 21 | 23 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. NOK) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 175 | 122 | 408 | 449 | 582 |
| Summe Anlagevermögen | 4 | 68 | 70 | 80 | 73 |
| Summe Aktiva | 179 | 190 | 478 | 530 | 656 |
Bilanz (in Mio. NOK) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 12 | 30 | 33 | 41 | 62 |
| Summe Eigenkapital | 166 | 160 | 445 | 488 | 593 |
| Summe Passiva | 179 | 190 | 478 | 530 | 656 |